Clinical Review Report: Latanoprostene Bunod (Vyzulta): (Bausch Health, Canada Inc.) [Internet]
- PMID: 31742961
- Bookshelf ID: NBK549676
Clinical Review Report: Latanoprostene Bunod (Vyzulta): (Bausch Health, Canada Inc.) [Internet]
Excerpt
The objective of this review was to perform a systematic review of the beneficial and harmful effects of latanoprostene bunod 0.024% ophthalmic solution for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Copyright © 2019 Canadian Agency for Drugs and Technologies in Health.
Sections
- Abbreviations
- Executive Summary
- Introduction
- Objectives and Methods
- Results
- Discussion
- Conclusions
- Appendix 1. Patient Input Summary
- Appendix 2. Literature Search Strategy
- Appendix 3. Excluded Studies
- Appendix 4. Detailed Outcome Data
- Appendix 5. Validity of Outcome Measures
- Appendix 6. Summary of Other Studies (Open-label Extension for APOLLO and LUNAR, and JUPITER)
- Appendix 7. Summary of Indirect Comparisons
- References